Anti-Bcl2 antibody [100/D5] (ab692)

ab692 has been referenced in 15 publications.

1. Jiao LR et al. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS One 7:e32068 (2012). WB; Human. PubMed: 22384141
2. Clark SE et al. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br J Cancer 104:120-7 (2011). IHC-P; Human. PubMed: 21139586
3. Zhao B et al. Effects of matrine on proliferation and apoptosis of cultured retinoblastoma cells. Graefes Arch Clin Exp Ophthalmol : (2011). WB; Human. PubMed: 21866335
4. Heazell AE et al. Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblast. Apoptosis 16:135-44 (2011). WB, IHC-P; Human. PubMed: 21052841
5. Ottewell PD et al. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Mol Cancer Ther 8:2821-32 (2009). WB; Mouse. PubMed: 19789217
6. Alderson LM et al. Human gliomas with wild-type p53 express bcl-2. Cancer Res 55:999-1001 (1995). PubMed: 7867012
7. Hurlimann J et al. bcl-2 protein in invasive ductal breast carcinomas. Virchows Arch 426:163-8 (1995). PubMed: 7757287
8. Symmans WF et al. Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation. Acta Cytol 39:673-82 (1995). PubMed: 7631541
9. Triscott JA et al. Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasias. J Cutan Pathol 22:2-10 (1995). PubMed: 7751474
10. Bhargava V et al. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145:535-40 (1994). PubMed: 8080038
11. Joensuu H et al. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191-8 (1994). PubMed: 7977649
12. Nathan B et al. Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group. Ann Oncol 5:409-14 (1994). PubMed: 7915536
13. Doussis IA et al. An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease. Am J Clin Pathol 99:663-7 (1993). PubMed: 8322700
14. Zutter M et al. Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood 78:1062-8 (1991). PubMed: 1868240
15. Hua C et al. Mechanism of bcl-2 activation in human follicular lymphoma. Oncogene 5:233-5 (1990). PubMed: 2181381